ArticleCerebellum (London, England)2025

miR-512-3p as a Potential Biomarker of Poor Outcome in Pediatric Medulloblastoma.

Carolina Alves Pereira Corrêa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.